| Ticker | KYMR |
|---|---|
| ISIN | US5015751044 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, general pustular psoriasis, and rheum...
El precio actual de Kymera Therapeutics, Inc. (KYMR) es de 84,91 , con una variación del -2,59%.
Kymera Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.